925 related articles for article (PubMed ID: 17606561)
1. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
[TBL] [Abstract][Full Text] [Related]
2. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
[TBL] [Abstract][Full Text] [Related]
4. Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.
Kawano A; Yanagizono T; Kadouchi I; Umezaki T; Chosa E
J Orthop Sci; 2018 Mar; 23(2):389-393. PubMed ID: 29146092
[TBL] [Abstract][Full Text] [Related]
5. AbobotulinumtoxinA Efficacy and Safety in Children With Equinus Foot Previously Treated With Botulinum Toxin.
Dabrowski E; Bonikowski M; Gormley M; Volteau M; Picaut P; Delgado MR
Pediatr Neurol; 2018 May; 82():44-49. PubMed ID: 29625849
[TBL] [Abstract][Full Text] [Related]
6. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
Bar-On L; Van Campenhout A; Desloovere K; Aertbeliën E; Huenaerts C; Vandendoorent B; Nieuwenhuys A; Molenaers G
Arch Phys Med Rehabil; 2014 Mar; 95(3):515-23. PubMed ID: 23994052
[TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
8. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
9. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
Büyükavcı R; Büyükavcı MA
Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
[TBL] [Abstract][Full Text] [Related]
10. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
[TBL] [Abstract][Full Text] [Related]
13. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy].
Kurenkov AL; Klochkova OA; Bursagova BI; Karimova HM; Kuzenkova LM; Mamedyarov AM; Namazova-Baranova LS; Agranovich OV; Agranovich AO; Soboleva OA; Khapaeva MM; Batysheva TT; Sarzhina MN
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):37-44. PubMed ID: 29265085
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
Ade-Hall RA; Moore AP
Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
[TBL] [Abstract][Full Text] [Related]
17. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.
Ubhi T; Bhakta BB; Ives HL; Allgar V; Roussounis SH
Arch Dis Child; 2000 Dec; 83(6):481-7. PubMed ID: 11087280
[TBL] [Abstract][Full Text] [Related]
18. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
[TBL] [Abstract][Full Text] [Related]
20. Multilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study.
Unlu E; Cevikol A; Bal B; Gonen E; Celik O; Kose G
Clinics (Sao Paulo); 2010 Jun; 65(6):613-9. PubMed ID: 20613938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
